Michael Meng


Michael has been investing in and working with healthcare companies for the past decade. He currently is the Chairman, & CEO of Stellar Health, a healthcare tech company focused on helping payors and providers deliver value-based care. Previously, Michael was a Principal in the Healthcare Group at Apax Partners, a large cap global private equity firm. He has served on the board of companies ranging from $50m to $3bn+ enterprise value with key deals including, Vyaire Medical, Ideal Protein, Medicomp, One Call Care Management, Qualitest Pharamceuticals, and TriZetto. In addition, he currently serves on the board of the CUNY School of Public Health and Global Language Project. Prior to Apax, Michael was an investment banker at Lazard Frères also focused on healthcare. He received his Bachelors degree from Michigan and an MBA from Wharton.